New EBR Feature: Linking Microbiome Activity with Metabolomics
What can metabolomics tell us about a microbial community beyond which microorganisms are present?
A new Novogene Europe article by Dr Shi-qi An and Dongqin Li, published in the Autumn 2026 issue of European Biopharmaceutical Review, explores how untargeted metabolomics can add a functional dimension to microbiome research by revealing the metabolic activity associated with microbial communities and host–microbiome interactions.
The article also considers key challenges in interpreting metabolomics data, from linking metabolites to their biological source to building confidence in metabolite identification.
Read the full article in European Biopharmaceutical Review.
European Biopharmaceutical Review, Autumn 2026, pages 64-67. © Samedan Ltd.